Deutsche Bank’s Profound Medical PROF Stock Holding History

Deutsche Bank’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,700	Closed	-$75K	–	4748
2021 Q1	$75K	Sell	3,700 -33,500	-90%	-$803K	﹤0.01%	4113
2020 Q4	$765K	Buy	37,200 +29,100	+359%	+$535K	﹤0.01%	2635
2020 Q3	$143K	Buy	8,100 +7,100	+710%	+$113K	﹤0.01%	3387
2020 Q2	$17K	Sell	1,000 -500	-33%	-$6.31K	﹤0.01%	4066
2020 Q1	$15K	Buy	1,500 +150	+11%	+$1.95K	﹤0.01%	3982
2019 Q4	$14K	Buy	+1,350	New	+$12.4K	﹤0.01%	4406

Other funds holding PROF

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Deutsche Bank's PROF Position: Q2 2021 in Review

Deutsche Bank sold out of Profound Medical (PROF) in Q2 2021, closing a stake of 3,700 shares — an estimated $75K sold.

Deutsche Bank first reported a position in PROF in Q4 2019 and held it in 6 quarters. The position peaked at $765K in Q4 2020. 48 funds tracked by Wall St. Rank hold PROF as of Q2 2021.

Deutsche Bank reported no remaining Profound Medical position as of Q2 2021 after selling out during the quarter.
Deutsche Bank sold 3,700 Profound Medical shares in Q2 2021, an estimated $75K.
Deutsche Bank first reported a position in Profound Medical in Q4 2019 and held it in 6 quarters.
Deutsche Bank's Profound Medical position peaked at $765K in Q4 2020.
48 funds tracked by Wall St. Rank held Profound Medical as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.